KDELR2 is an unfavorable prognostic biomarker and regulates CCND1 to promote tumor progression in glioma
Authors:
- 1 July 2020
- journal article
- research article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 216 (7) , 152996
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 29 references indexed in Scilit:
- The KDEL receptor couples to Gαq/11 to activate Src kinases and regulate transport through the GolgiThe EMBO Journal, 2012
- The KDEL receptor induces autophagy to promote the clearance of neurodegenerative disease-related proteinsNeuroscience, 2011
- Loss of PI3K blocks cell-cycle progression in a Drosophila tumor modelOncogene, 2011
- Cyclin D1/Cyclin-Dependent Kinase 4 Interacts with Filamin A and Affects the Migration and Invasion Potential of Breast Cancer CellsCancer Research, 2010
- The KDEL receptor: New functions for an old proteinFEBS Letters, 2009
- A molecular specificity code for the three mammalian KDEL receptorsJournal of Cell Biology, 2007
- The Retrieval Function of the KDEL Receptor Requires PKA Phosphorylation of Its C-TerminusMolecular Biology of the Cell, 2003
- The KDEL Receptor Modulates the Endoplasmic Reticulum Stress Response through Mitogen-activated Protein Kinase Signaling CascadesJournal of Biological Chemistry, 2003
- Ligand-induced redistribution of a human KDEL receptor from the Golgi complex to the endoplasmic reticulumCell, 1992
- A human homologue of the yeast HDEL receptorNature, 1990